(Reuters) – Synairgen Plc (SYNG.L) said Monday that his drug helped reduce the risk of serious cases in hospitalized patients with COVID-19, according to data from a trial of more than 100 people in the UK, which triggered his actions. The trial, which used interferon beta, showed that patients who …
Read More »
(Reuters) – The leading US infectious disease expert, Dr. Anthony Fauci, predicted Wednesday that the country will reach its goal of a coronavirus vaccine by the end of the year and was not moved by the possibility that China would come first. FILE PHOTO: Dr. Anthony Fauci, Director of the …
Read More »
(Reuters) – Moderna Inc’s (MRNA.O) Stocks increased by about 11% on Wednesday after a small-scale study showed that its experimental COVID-19 vaccine produced high levels of virus-killing antibodies, raising hopes that the vaccine could be effective in later stages of testing. FILE PHOTO: A sign marks the headquarters of Moderna …
Read More »
LONDON (Reuters) – Emerging evidence that the body’s immune defense against COVID-19 may be short-lived makes it even more difficult for vaccine developers to find vaccines fully capable of protecting people in future waves of infection, Scientists said Tuesday. FILE PHOTO: Professor Gottfried Kremsner injects a coronavirus disease vaccine (COVID-19) …
Read More »
CHICAGO (Reuters) – Moderna Inc’s (MRNA.O) The experimental vaccine for COVID-19 was shown to be safe and elicited immune responses in all 45 healthy volunteers in an early-stage study, US researchers reported Tuesday. The volunteers who received two doses of the vaccine had high levels of anti-virus antibodies that exceeded …
Read More »